Currently, there are 1.29B common shares owned by the public and among those 1.28B shares have been available to trade.
The company’s stock has a 5-day price change of -5.86% and -8.44% over the past three months. LRCX shares are trading -8.34% year to date (YTD), with the 12-month market performance down to -4.91% lower. It has a 12-month low price of $68.87 and touched a high of $113.00 over the same period. LRCX has an average intraday trading volume of 12.41 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.78%, -4.65%, and -17.70% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Lam Research Corp (NASDAQ: LRCX) shares accounts for 78.49% of the company’s 1.29B shares outstanding.
It has a market capitalization of $93.12B and a beta (3y monthly) value of 1.46. The stock’s trailing 12-month PE ratio is 23.23, while the earnings-per-share (ttm) stands at $3.09. The company has a PEG of 1.50 and a Quick Ratio of 1.74 with the debt-to-equity ratio at 0.59. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.03% over the week and 3.65% over the month.
Earnings per share for the fiscal year are expected to increase by 16.98%, and 16.98% over the next financial year. EPS should shrink at an annualized rate of 15.51% over the next five years, compared to 16.17% over the past 5-year period.
TD Cowen coverage for the Lam Research Corp (LRCX) stock in a research note released on August 01, 2024 offered a Buy rating with a price target of $1050. Jefferies was of a view on May 13, 2024 that the stock is Buy, while TD Cowen gave the stock Buy rating on April 25, 2024, issuing a price target of $975- $1000. B. Riley Securities on their part issued Buy rating on April 19, 2024.
